Key Takeaways
- Industry-leading growth, guidance raised: Revenue grew 32% YoY (₹2,100 cr), the highest constant-currency YoY growth in 14 quarters, prompting an FY25 CC growth upgrade to 21.8%–22.3%.
- Margins held steady through investment: EBIT margin was stable at 11.1% despite continued spending on sales, capabilities and brand; normalized FY25 margin is expected in the 11%–11.5% band.
- The deal engine is firing consistently: Three large deals signed, marking the third straight quarter of at least three large-deal wins, and the Q3 exit pipeline was among the highest ever.
- Portfolio reshaping is showing up in the numbers: Client concentration fell meaningfully (top-5 share down to 29.2% from 35.8%) while healthcare grew 31% YoY and the Ascensos acquisition added nearshore scale.
- What to watch next quarter: Whether the Q4 healthcare deal closures materialize, the pace of DSO normalization back from 67 days, and any early signal on FY26 growth when Q4 numbers land.
Growth & Demand Environment
- Broad-based momentum: Revenue grew 32% YoY with the fifth straight quarter of over 3% QoQ CC growth; 80% of the QoQ move came from the full-quarter impact of Ascensos, but organic growth was well distributed across geographies and verticals.
- Geographic spread: North America grew 1.3% QoQ, Europe jumped ~22% QoQ, and Australia began executing on a multi-tower telco deal with a strong pipeline behind it. UK clients facing cost pressure are actively exploring offshore and nearshore options, playing to Firstsource's South Africa and Romania delivery.
- Healthcare paused, not stalled: Healthcare revenue was flat QoQ as the payer segment slowed temporarily ahead of open enrollment and the US elections; deal conversations have since resumed actively and management expects Q4 closures.
- Deal ramp is deliberately staggered: Several transformative deals carry a slower, non-linear ramp curve (upfront assessment, gradual scale, outcome-linked commercials) that will convert to reported revenue over an extended period, a dynamic investors need to model rather than expect a step-change.
- Client broad-basing is working: Share of top-5 clients fell to 29.2% from 35.8% and top-10 to 43.5% from 52%, visible proof that the strategy of building multiple growth engines is taking hold.
Idnani: "These are visible signs of the success of our initiatives to broad-base our revenues and build multiple growth engines."
Deal Wins & Pipeline
Three large deals signed in Q3, the third consecutive quarter of at least three wins. The pipeline exiting Q3 was among the highest ever, and management expressed confidence in sustaining the accelerated win momentum.
| Deal | Details |
|---|---|
| Top-10 NA healthcare payer | Existing customer; selected to process their entire claims operations, a transformative scope expansion. |
| Top-3 NA consumer tech (GenAI) | Firstsource selected to develop and evaluate content across multiple domains, validating and optimizing the client's GenAI model. |
| Large UK utility (expansion) | Existing client; expanded scope across customer support and collections. |
| Australia healthcare insurer | Won from one of the largest healthcare insurers in Australia, building on the beachhead created by the earlier telco win. |
- New logo engine: 13 new logos added, including five strategic logos with potential of at least US$5 million annual revenue each; BFS added seven, healthcare added five, and CMT added one.
- BPaaS pipeline building: A new healthcare BPaaS service line combining operations with technology and systems integration has been built; a strong deal pipeline is in place and management is hopeful of meaningful conversions in the coming quarter.
- Europe carve-out opportunity: Increased conversations around carve-out sales are driving a significant build-up in the European deal pipeline.
Idnani: "I believe that the strength of our deal wins and pipelines reflects our success in leveraging our deep industry and functional expertise, our partnerships in the technology ecosystem, and our ability to proactively bring automation and AI into the mix that is resonating well with our clients."
AI & Technology Strategy
- GenAI services gaining traction: A top-three North American consumer tech company selected Firstsource for GenAI model development and validation work; this is the fourth logo among the top five consumer tech firms for AI services, and the AccunAI acquisition was partly driven by the need to bring AI development capability in-house for such clients.
- AccunAI tuck-in: Acquired a Jaipur-based AI development services startup for ₹8 crore total consideration; AccunAI was already a vendor to Firstsource for AI development and crowdsourcing, so the deal internalizes a known capability.
- CX portfolio refreshed with AI: The CX portfolio has been refreshed with AI-tech-enabled components targeting a 10x improvement in customer experience and outcome delivery; this is percolating to the Ascensos client base alongside GenAI studio and agentic AI for the retail value chain.
- AI's impact on BPS headcount: Management's stance is that AI-augmented humans will replace non-AI-using humans, not that AI eliminates roles wholesale; 150,000 learning hours have been completed on GenAI and digital transformation to date.
- Algorithmic innovation matters as much as scale: Management noted that DeepSeek-style algorithmic breakthroughs are rapidly pushing down training costs, reinforcing that scaling compute is not the only path to AI progress, a dynamic that could lower barriers for mid-sized players like Firstsource.
Idnani: "What we are seeing today is that a human who leverages AI for their day-to-day work will replace a human who doesn't use AI."
Vertical & Segment Performance
| Vertical / Segment | Trend | Commentary |
|---|---|---|
| Healthcare | ▲ Strong YoY, flat QoQ | Grew 31% YoY; QoQ pause from payer slowdown ahead of open enrollment and elections; deal conversations resumed, Q4 closures expected. |
| BFS | ▲ Steady | Added 7 new logos; collections platform delivering results; US consumer resilient despite delinquency uptick; mortgage refi volumes remain structurally suppressed with 80% of fixed-rate loans still at 5% or below. |
| Consumer Tech (AI services) | ▲ Emerging | Fourth top-five consumer tech logo added for AI services; GenAI model validation and optimization work is a new, fast-growing sub-segment. |
| Retail & Utilities | ▲ Pipeline-driven | Healthy deal pipeline expected to translate into broad-based growth in coming quarters; Ascensos jump-started retail presence. |
| Australia | ▲ Early ramp | Multi-tower telco deal in execution; healthcare insurer win in Q3; strong pipeline. |
| Europe | ▲ Surge | ~22% QoQ growth; carve-out conversations building pipeline; UK cost-pressure driving offshore/nearshore interest. |
- Mortgage reality check: With ~80% of outstanding US fixed-rate mortgages still at 5% or lower, refi volumes are structurally suppressed and unlikely to return quickly, a headwind management is not sugar-coating.
Idnani: "If you look at the Fannie Mae data, about 80% of the outstanding fixed rate mortgage loans are still at 5% or less from an interest rate standpoint. So, it's very clear that refi volumes are unlikely to come back very quickly, and anybody else who is selling you otherwise is probably smoking something else."
Margins & Investment Cycle
- Margin stability through investment: EBIT margin held at 11.1%, flat QoQ and YoY, even as the company continued investing across three fronts: sales and account teams (headcount up over 50% in 12 months), capability building (leadership hires, solutions team, AI/automation portfolio modernization), and brand amplification with analysts and advisors.
- The 24-lever margin playbook: Management is tracking ~24 value levers to drive the promised 50–75 bps annual margin expansion from FY26. The single largest structural lever is the shift from 74% onshore / 26% offshore to 60% / 40%, supplemented by employee pyramid optimization, centralizing and automating support functions, and using AI in onboarding and training to improve speed-to-competence.
- Cash conversion temporarily stretched: DSO rose to 67 days from 65 days in Q2, described as a normal soft-collection quarter in the US; FCF to PAT was a strong 159% in Q3, but nine-month OCF growth lagged EBITDA growth because of a very high DSO in Q1. Management expects normalization in Q4.
- Acquisition philosophy is capability-led, not revenue-led: Each of the three acquisitions in the past year addressed a specific, value-accretive capability gap; the strategy is centered on organic growth, with M&A treated as binary and opportunistic.
Competitive Positioning
- Challenger advantage: Management argues that at Firstsource's size and scale, it can be more agile, nimble and responsive than larger incumbents, some of whom are playing defense to protect existing business or are distracted by post-merger integration challenges from large acquisitions.
- Domain-plus-technology as the wedge: The combination of deep domain expertise with technology contextualized to that domain is, in management's view, what is allowing Firstsource to take share and win against larger players.
- Ascensos as a strategic platform: The acquisition added nearshore delivery in the UK, multilingual support, and a retail client base; post-acquisition value is being driven by offering Ascensos clients access to Firstsource's India, Philippines and Mexico delivery locations, front-end consulting capabilities, and the AI-refreshed CX technology portfolio.
Idnani: "At our size and scale, what it allows us to do is to be the challenger to incumbents, and the combination of deep domain and technology contextualized to the domain, I think is allowing us to take, share, and win against the larger players."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY25 revenue growth | 21.8%–22.3% constant currency | FY25 full year |
| FY25 EBIT margin | 11%–11.5% normalized band (excl. one-time acquisition charges) | FY25 full year |
| Annual margin expansion | 50–75 bps per year | Starting FY26, over the medium term |
| DSO normalization | DSO to revert from 67 days; full-year OCF-to-EBITDA to normalize | Q4 FY25 |
| Healthcare deal closures | Several closures expected | Q4 FY25 |
| FY26 growth commentary | No specifics yet; color to be provided with Q4 results | Q4 FY25 earnings |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue | ₹2,102.4 cr, 32% YoY and 8.4% QoQ in USD terms |
| Constant currency revenue growth | 7.6% QoQ, 28% YoY; fifth straight quarter of over 3% QoQ CC growth |
| EBIT margin | 11.1%, broadly stable QoQ and YoY |
| Operating profit | ₹233.3 cr, up 37% YoY |
| Net profit | ₹160.3 cr, 16% QoQ and 25% YoY growth |
| Diluted EPS | ₹2.27 |
| Tax rate | 20% for the quarter and nine months |
| FY25 constant currency revenue growth guidance | 21.8% to 22.3% |
| FY25 normalized EBIT margin guidance | 11% to 11.5% band, excluding one-time acquisition-related charges |
| Large deal wins | 3 in Q3, third consecutive quarter with at least three large deal wins |
| New logos added | 13, including 5 strategic logos (potential of at least US$5 million annual revenue) |
| Total headcount | 34,144, net addition of 1,246 in Q3 |
| Trailing 12-month attrition | 31.4%, up from 30.6% in Q2 |
| BFS vertical constant currency growth | 1.6% QoQ, 8% YoY; 7 new logos added |
| Healthcare vertical constant currency growth | Flat QoQ, 31% YoY; 5 new logos added |
| CMT vertical constant currency growth | 3% QoQ, 14% YoY; 1 new logo added |
| Diverse portfolio constant currency growth | 80% QoQ, 193% YoY, including full-quarter impact of Ascensos acquisition |
| North America constant currency growth | 1.3% QoQ, 28% YoY |
| Europe constant currency growth | ~22% QoQ, 28% YoY |
| Onshore revenue share | 60%, down from ~74% in Q2 of last year; offshore and nearshore at 40% |
| Top 5 client revenue concentration | 29.2%, down from 35.8% in Q3 last year |
| Top 10 client revenue concentration | 43.5%, down from 52% in Q3 last year |
| Reported DSO | 67 days, up from 65 days in Q2 |
| FCF to PAT | 159% in Q3, 78% for 9MFY25 |
| Cash balance including investments | ₹250 cr |
| Net debt | ₹1,020 cr at end of Q3 |
| Interim dividend | ₹4 per share |
| Net one-time gain | ₹8.8 cr, including ₹65.1 cr contingent consideration writeback, ₹28.4 cr intangible useful life charge, ₹13 cr potential credit loss, ₹15 cr special bonus provision |
| Women in workforce | 46% |
| GenAI and digital transformation learning hours | ~150,000 completed |
| ESG score | 81 by S&P Global, top 99th percentile of DJSI 2024 |
| AccunAI acquisition consideration | ₹8 cr, 100% acquisition |